140 related articles for article (PubMed ID: 34368436)
1. Medication Adherence in Type 2 Diabetes Mellitus: A Qualitative Exploration of Barriers and Facilitators From Socioecological Perspectives.
Onwuchuluba EE; Oyetunde OO; Soremekun RO
J Patient Exp; 2021; 8():23743735211034338. PubMed ID: 34368436
[TBL] [Abstract][Full Text] [Related]
2. Patient Perspective on Iron Chelation Therapy: Barriers and Facilitators of Medication Adherence.
Chong CC; Redzuan AM; Sathar J; Makmor-Bakry M
J Patient Exp; 2021; 8():2374373521996958. PubMed ID: 34179377
[TBL] [Abstract][Full Text] [Related]
3. Patients' perspective of disease and medication adherence for type 2 diabetes in an urban area in Bangladesh: a qualitative study.
Islam SM; Biswas T; Bhuiyan FA; Mustafa K; Islam A
BMC Res Notes; 2017 Mar; 10(1):131. PubMed ID: 28327202
[TBL] [Abstract][Full Text] [Related]
4. A qualitative exploration of barriers to medication adherence among patients with uncontrolled diabetes in Qatar: integrating perspectives of patients and health care providers.
Jaam M; Hadi MA; Kheir N; Mohamed Ibrahim MI; Diab MI; Al-Abdulla SA; Awaisu A
Patient Prefer Adherence; 2018; 12():2205-2216. PubMed ID: 30410316
[TBL] [Abstract][Full Text] [Related]
5. Barriers and Facilitators of Adherence to Oral Anticancer Medications Among Women with Breast Cancer: A Qualitative Study.
Onwusah DO; Ojewole EB; Manyangadze T; Chimbari MJ
Patient Prefer Adherence; 2023; 17():2821-2839. PubMed ID: 37953981
[TBL] [Abstract][Full Text] [Related]
6. Barriers and facilitators of medication adherence in hypertensive African Americans: a qualitative study.
Ogedegbe G; Harrison M; Robbins L; Mancuso CA; Allegrante JP
Ethn Dis; 2004; 14(1):3-12. PubMed ID: 15002917
[TBL] [Abstract][Full Text] [Related]
7. Barriers and facilitators of adherence to antidepressants among outpatients with major depressive disorder: A qualitative study.
Ho SC; Jacob SA; Tangiisuran B
PLoS One; 2017; 12(6):e0179290. PubMed ID: 28614368
[TBL] [Abstract][Full Text] [Related]
8. Patients' perspective of barriers and facilitators to taking long-term controller medication for asthma: a novel taxonomy.
Peláez S; Lamontagne AJ; Collin J; Gauthier A; Grad RM; Blais L; Lavoie KL; Bacon SL; Ernst P; Guay H; McKinney ML; Ducharme FM
BMC Pulm Med; 2015 Apr; 15():42. PubMed ID: 25907709
[TBL] [Abstract][Full Text] [Related]
9. Factors Impacting Adherence to Diabetes Medication Among Urban, Low Income Mexican-Americans with Diabetes.
Baghikar S; Benitez A; Fernandez Piñeros P; Gao Y; Baig AA
J Immigr Minor Health; 2019 Dec; 21(6):1334-1341. PubMed ID: 30798408
[TBL] [Abstract][Full Text] [Related]
10. Barriers to medication taking among Kuwaiti patients with type 2 diabetes: a qualitative study.
Jeragh-Alhaddad FB; Waheedi M; Barber ND; Brock TP
Patient Prefer Adherence; 2015; 9():1491-503. PubMed ID: 26604702
[TBL] [Abstract][Full Text] [Related]
11. Understanding medication adherence among patients of Turkish descent with type 2 diabetes: a qualitative study.
Peeters B; Van Tongelen I; Duran Z; Yüksel G; Mehuys E; Willems S; Remon JP; Boussery K
Ethn Health; 2015; 20(1):87-105. PubMed ID: 24588791
[TBL] [Abstract][Full Text] [Related]
12. "Why Am I Not Taking Medications?" Barriers and Facilitators of Diabetes Medication Adherence Across Different Health Literacy Levels.
Huang YM; Pecanac KE; Shiyanbola OO
Qual Health Res; 2020 Dec; 30(14):2331-2342. PubMed ID: 32723206
[TBL] [Abstract][Full Text] [Related]
13. Medication Adherence Changes in Blacks with Diabetes: A Mixed Methods Study.
Rao D; Maurer M; Meyer J; Zhang J; Shiyanbola OO
Am J Health Behav; 2020 Mar; 44(2):257-270. PubMed ID: 32019658
[No Abstract] [Full Text] [Related]
14. Barriers and facilitators of medication reconciliation processes for recently discharged patients from community pharmacists' perspectives.
Kennelty KA; Chewning B; Wise M; Kind A; Roberts T; Kreling D
Res Social Adm Pharm; 2015; 11(4):517-30. PubMed ID: 25586885
[TBL] [Abstract][Full Text] [Related]
15. Qualitative Exploration of Barriers to Medication Adherence Among Patients with Uncontrolled Diabetes in Saudi Arabia.
Alodhaib G; Alhusaynan I; Mirza A; Almogbel Y
Pharmacy (Basel); 2021 Jan; 9(1):. PubMed ID: 33440884
[TBL] [Abstract][Full Text] [Related]
16. The barriers and facilitators people with diabetes from a nonEnglish speaking background experience when managing their medications: a qualitative study.
Claydon-Platt K; Manias E; Dunning T
J Clin Nurs; 2014 Aug; 23(15-16):2234-46. PubMed ID: 24372586
[TBL] [Abstract][Full Text] [Related]
17. Using the theoretical domains framework to determine the barriers and facilitators to medication adherence in Parkinson's disease.
Smith JC; Seage CH; Lane E; James DH
Explor Res Clin Soc Pharm; 2023 Sep; 11():100309. PubMed ID: 37583935
[TBL] [Abstract][Full Text] [Related]
18. Barriers and Facilitators of Using Sensored Medication Adherence Devices in a Diverse Sample of Patients With Multiple Myeloma: Qualitative Study.
Asfaw AA; Yan CH; Sweiss K; Wirth S; Ramirez VH; Patel PR; Sharp LK
JMIR Cancer; 2018 Nov; 4(2):e12. PubMed ID: 30425032
[TBL] [Abstract][Full Text] [Related]
19. Clinical pharmacists' perspective of medication adherence support in Ethiopian hospital settings: a qualitative study.
Tegegn HG; Wark S; Tursan d'Espaignet E; Spark MJ
Int J Pharm Pract; 2023 Dec; 31(6):617-624. PubMed ID: 37721550
[TBL] [Abstract][Full Text] [Related]
20. Barriers and facilitators to adherence to anti-diabetic medications: Ethiopian patients' perspectives.
Habte BM; Kebede T; Fenta TG; Boon H
Afr J Prim Health Care Fam Med; 2017 Oct; 9(1):e1-e9. PubMed ID: 29113442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
